
Supriya Life Sciences IPO
Supriya Life Sciences IPO Price Range is ₹265 - ₹274, with a minimum investment of ₹14,796 for 54 shares per lot.
Minimum Investment
₹14,796
/ 54 shares
IPO Status
Price Band
₹265 - ₹274
Bidding Dates
Dec 16, 2021 - Dec 20, 2021
Lot Size
54 shares
Min Investment
₹14,796
Listing Exchange
NSE
Supriya Life Sciences IPO Application Timeline



How to Apply for Supriya Life Sciences IPO on INDmoney
- Download the INDmoney app and complete your KYC.
- Go to INDstocks → IPO, or just search “IPO”.
- Tap on Supriya Life Sciences IPO from the list of live IPOs.
- View key details like price band, lot size, and dates.
- Tap Apply Now and choose your number of lots.
- Use INDpay UPI for instant mandate tracking.
- Your funds will be blocked until the share allotment is finalized.
About Supriya Life Sciences
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs).
Frequently Asked Questions of Supriya Life Sciences IPO
What is the allotment date of the Supriya Life Sciences IPO?
Supriya Life Sciences IPO allotment date is Dec 23, 2021 (tentative).
What are the open and close dates of the Supriya Life Sciences IPO?
The Supriya Life Sciences IPO will open on Dec 16, 2021 and close on Dec 20, 2021
What is the lot size of Supriya Life Sciences IPO?
The lot size for the Supriya Life Sciences IPO is 54.
When will my Supriya Life Sciences IPO order be placed?
Your Supriya Life Sciences IPO order will be placed on Dec 16, 2021
Can we invest in Supriya Life Sciences IPO?
Yes, once Supriya Life Sciences IPO opens, you can invest in the shares of the company.
What would be the listing gains on the Supriya Life Sciences IPO?
The potential listing gains on the Supriya Life Sciences IPO will depend on various market factors and cannot be predicted with certainty.
What is 'pre-apply' for Supriya Life Sciences IPO?
'Pre-apply' for Supriya Life Sciences IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.